Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1353456

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1353456

Europe Pruritus Therapeutics Market Size, Share & Industry Trends Analysis Report By Disease Type, By Product, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 135 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Europe Pruritus Therapeutics Market would witness market growth of 4.1% CAGR during the forecast period (2023-2030).

For severe and ongoing pruritus, systemic medication such as antihistamines, antidepressants, immunosuppressants, and opioid antagonists are administered. These drugs either affect the central nervous system's itch pathway or the underlying cause of pruritus. Light therapy, or phototherapy, uses ultraviolet (UV) light to treat pruritus caused by skin conditions such as psoriasis and irritation. The skin's condition improves with UV light, which helps suppress inflammation and ease itching. Modifying one's lifestyle, avoiding triggers, maintaining proper skin hygiene, utilizing gentle skincare products, and managing anxiety can complement pharmacological treatments and alleviate pruritus.

One of the emerging market trends is the use of cutting-edge technology in creating products to treat fungal infections, including pruritus. This method allows for the use of typically unsoluble medications, increasing the drug's bioavailability and effectiveness in tablet form. Thus, developing and distributing pharmaceuticals using innovative technology helps increase their efficacy, thereby improving therapy alternatives. These technological developments will encourage the market to grow favorably. The market is progressing due to regulatory agencies' increased special designation. Additionally, the market will benefit from profitable growth prospects due to the rise in demand for over-the-counter topical corticosteroids.

The U.K. government's "Future of an Aging Population" study estimates that by 2040, one in seven citizens will be over 75. By 2037, 1.42 million more families, or an increase of 161% over 25 years, are expected to be headed by an individual who is 85 years or older. Over 5.5 million more people are anticipated to contribute to the percentage of working-age people over 50 and at the state pension age (SPA), which is predicted to increase from 26% in 2012 to 34% in 2050. Due to aging-related skin changes and a higher prevalence of specific underlying disorders, elderly people are more likely to experience pruritus. Because of this, the regional market will expand due to the aging population.

The Germany market dominated the Europe Pruritus Therapeutics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $751.4 million by 2030. The UK market is anticipated to grow at a CAGR of 3.3% during (2023 - 2030). Additionally, The France market would exhibit a CAGR of 4.9% during (2023 - 2030).

Based on Disease Type, the market is segmented into Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria and Others. Based on Product, the market is segmented into Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors and Others. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bristol Myers Squibb Company, Novartis AG, Pfizer, Inc., Sanofi S.A., Astellas Pharma, Inc., Cara Therapeutics, Inc., GlaxoSmithKline PLC (GSK), Teva Pharmaceuticals Industries Ltd., Amgen, Inc., and AbbVie, Inc.

Scope of the Study

Market Segments covered in the Report:

By Disease Type

  • Atopic Dermatitis
  • Allergic Contact Dermatitis
  • Urticaria
  • Others

By Product

  • Corticosteroids
  • Antihistamines
  • Local Anesthetics
  • Counterirritants
  • Immunosuppressant
  • Calcineurin Inhibitors
  • Others

By Distribution Channel

  • Drug Stores & Retail Pharmacies
  • Hospital Pharmacies
  • Online Providers

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • Bristol Myers Squibb Company
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi S.A.
  • Astellas Pharma, Inc.
  • Cara Therapeutics, Inc.
  • GlaxoSmithKline PLC (GSK)
  • Teva Pharmaceuticals Industries Ltd.
  • Amgen, Inc.
  • AbbVie, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Pruritus Therapeutics Market, by Disease Type
    • 1.4.2 Europe Pruritus Therapeutics Market, by Product
    • 1.4.3 Europe Pruritus Therapeutics Market, by Distribution Channel
    • 1.4.4 Europe Pruritus Therapeutics Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter's Five Force Analysis

Chapter 4. Europe Pruritus Therapeutics Market by Disease Type

  • 4.1 Europe Atopic Dermatitis Market by Country
  • 4.2 Europe Allergic Contact Dermatitis Market by Country
  • 4.3 Europe Urticaria Market by Country
  • 4.4 Europe Others Market by Country

Chapter 5. Europe Pruritus Therapeutics Market by Product

  • 5.1 Europe Corticosteroids Market by Country
  • 5.2 Europe Antihistamines Market by Country
  • 5.3 Europe Local Anesthetics Market by Country
  • 5.4 Europe Counterirritants Market by Country
  • 5.5 Europe Immunosuppressant Market by Country
  • 5.6 Europe Calcineurin Inhibitors Market by Country
  • 5.7 Europe Others Market by Country

Chapter 6. Europe Pruritus Therapeutics Market by Distribution Channel

  • 6.1 Europe Drug Stores & Retail Pharmacies Market by Country
  • 6.2 Europe Hospital Pharmacies Market by Country
  • 6.3 Europe Online Providers Market by Country

Chapter 7. Europe Pruritus Therapeutics Market by Country

  • 7.1 Germany Pruritus Therapeutics Market
    • 7.1.1 Germany Pruritus Therapeutics Market by Disease Type
    • 7.1.2 Germany Pruritus Therapeutics Market by Product
    • 7.1.3 Germany Pruritus Therapeutics Market by Distribution Channel
  • 7.2 UK Pruritus Therapeutics Market
    • 7.2.1 UK Pruritus Therapeutics Market by Disease Type
    • 7.2.2 UK Pruritus Therapeutics Market by Product
    • 7.2.3 UK Pruritus Therapeutics Market by Distribution Channel
  • 7.3 France Pruritus Therapeutics Market
    • 7.3.1 France Pruritus Therapeutics Market by Disease Type
    • 7.3.2 France Pruritus Therapeutics Market by Product
    • 7.3.3 France Pruritus Therapeutics Market by Distribution Channel
  • 7.4 Russia Pruritus Therapeutics Market
    • 7.4.1 Russia Pruritus Therapeutics Market by Disease Type
    • 7.4.2 Russia Pruritus Therapeutics Market by Product
    • 7.4.3 Russia Pruritus Therapeutics Market by Distribution Channel
  • 7.5 Spain Pruritus Therapeutics Market
    • 7.5.1 Spain Pruritus Therapeutics Market by Disease Type
    • 7.5.2 Spain Pruritus Therapeutics Market by Product
    • 7.5.3 Spain Pruritus Therapeutics Market by Distribution Channel
  • 7.6 Italy Pruritus Therapeutics Market
    • 7.6.1 Italy Pruritus Therapeutics Market by Disease Type
    • 7.6.2 Italy Pruritus Therapeutics Market by Product
    • 7.6.3 Italy Pruritus Therapeutics Market by Distribution Channel
  • 7.7 Rest of Europe Pruritus Therapeutics Market
    • 7.7.1 Rest of Europe Pruritus Therapeutics Market by Disease Type
    • 7.7.2 Rest of Europe Pruritus Therapeutics Market by Product
    • 7.7.3 Rest of Europe Pruritus Therapeutics Market by Distribution Channel

Chapter 8. Company Profiles

  • 8.1 Bristol Myers Squibb Company
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Regional Analysis
    • 8.1.4 Research & Development Expenses
    • 8.1.5 SWOT Analysis
  • 8.2 Novartis AG
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 SWOT Analysis
  • 8.3 Pfizer, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Regional & Segmental Analysis
    • 8.3.4 Research & Development Expense
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Approvals:
    • 8.3.6 SWOT Analysis
  • 8.4 Sanofi S.A.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 SWOT Analysis
  • 8.5 Astellas Pharma, Inc.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Regional Analysis
    • 8.5.4 Research & Development Expense
    • 8.5.5 SWOT Analysis
  • 8.6 Cara Therapeutics, Inc.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Research & Development Expenses
    • 8.6.4 Recent strategies and developments:
      • 8.6.4.1 Partnerships, Collaborations, and Agreements:
    • 8.6.5 SWOT Analysis
  • 8.7 GlaxoSmithKline PLC (GSK)
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Regional Analysis
    • 8.7.4 Research & Development Expense
    • 8.7.5 SWOT Analysis
  • 8.8 Teva Pharmaceutical Industries Ltd.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Regional Analysis
    • 8.8.4 Research & Development Expenses
    • 8.8.5 SWOT Analysis
  • 8.9 Amgen, Inc.
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Regional Analysis
    • 8.9.4 Research & Development Expenses
    • 8.9.5 SWOT Analysis
  • 8.10. AbbVie, Inc.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Regional Analysis
    • 8.10.4 Research & Development Expense
    • 8.10.5 Recent strategies and developments:
      • 8.10.5.1 Approvals & Trials:
    • 8.10.6 SWOT Analysis

LIST OF TABLES

  • TABLE 1 Europe Pruritus Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 2 Europe Pruritus Therapeutics Market, 2023 - 2030, USD Million
  • TABLE 3 Europe Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
  • TABLE 4 Europe Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
  • TABLE 5 Europe Atopic Dermatitis Market by Country, 2019 - 2022, USD Million
  • TABLE 6 Europe Atopic Dermatitis Market by Country, 2023 - 2030, USD Million
  • TABLE 7 Europe Allergic Contact Dermatitis Market by Country, 2019 - 2022, USD Million
  • TABLE 8 Europe Allergic Contact Dermatitis Market by Country, 2023 - 2030, USD Million
  • TABLE 9 Europe Urticaria Market by Country, 2019 - 2022, USD Million
  • TABLE 10 Europe Urticaria Market by Country, 2023 - 2030, USD Million
  • TABLE 11 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 12 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 13 Europe Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
  • TABLE 14 Europe Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
  • TABLE 15 Europe Corticosteroids Market by Country, 2019 - 2022, USD Million
  • TABLE 16 Europe Corticosteroids Market by Country, 2023 - 2030, USD Million
  • TABLE 17 Europe Antihistamines Market by Country, 2019 - 2022, USD Million
  • TABLE 18 Europe Antihistamines Market by Country, 2023 - 2030, USD Million
  • TABLE 19 Europe Local Anesthetics Market by Country, 2019 - 2022, USD Million
  • TABLE 20 Europe Local Anesthetics Market by Country, 2023 - 2030, USD Million
  • TABLE 21 Europe Counterirritants Market by Country, 2019 - 2022, USD Million
  • TABLE 22 Europe Counterirritants Market by Country, 2023 - 2030, USD Million
  • TABLE 23 Europe Immunosuppressant Market by Country, 2019 - 2022, USD Million
  • TABLE 24 Europe Immunosuppressant Market by Country, 2023 - 2030, USD Million
  • TABLE 25 Europe Calcineurin Inhibitors Market by Country, 2019 - 2022, USD Million
  • TABLE 26 Europe Calcineurin Inhibitors Market by Country, 2023 - 2030, USD Million
  • TABLE 27 Europe Others Market by Country, 2019 - 2022, USD Million
  • TABLE 28 Europe Others Market by Country, 2023 - 2030, USD Million
  • TABLE 29 Europe Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 30 Europe Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 31 Europe Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 32 Europe Drug Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 33 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
  • TABLE 34 Europe Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
  • TABLE 35 Europe Online Providers Market by Country, 2019 - 2022, USD Million
  • TABLE 36 Europe Online Providers Market by Country, 2023 - 2030, USD Million
  • TABLE 37 Europe Pruritus Therapeutics Market by Country, 2019 - 2022, USD Million
  • TABLE 38 Europe Pruritus Therapeutics Market by Country, 2023 - 2030, USD Million
  • TABLE 39 Germany Pruritus Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 40 Germany Pruritus Therapeutics Market, 2023 - 2030, USD Million
  • TABLE 41 Germany Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
  • TABLE 42 Germany Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
  • TABLE 43 Germany Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
  • TABLE 44 Germany Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
  • TABLE 45 Germany Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 46 Germany Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 47 UK Pruritus Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 48 UK Pruritus Therapeutics Market, 2023 - 2030, USD Million
  • TABLE 49 UK Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
  • TABLE 50 UK Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
  • TABLE 51 UK Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
  • TABLE 52 UK Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
  • TABLE 53 UK Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 54 UK Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 55 France Pruritus Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 56 France Pruritus Therapeutics Market, 2023 - 2030, USD Million
  • TABLE 57 France Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
  • TABLE 58 France Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
  • TABLE 59 France Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
  • TABLE 60 France Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
  • TABLE 61 France Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 62 France Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 63 Russia Pruritus Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 64 Russia Pruritus Therapeutics Market, 2023 - 2030, USD Million
  • TABLE 65 Russia Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
  • TABLE 66 Russia Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
  • TABLE 67 Russia Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
  • TABLE 68 Russia Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
  • TABLE 69 Russia Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 70 Russia Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 71 Spain Pruritus Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 72 Spain Pruritus Therapeutics Market, 2023 - 2030, USD Million
  • TABLE 73 Spain Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
  • TABLE 74 Spain Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
  • TABLE 75 Spain Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
  • TABLE 76 Spain Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
  • TABLE 77 Spain Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 78 Spain Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 79 Italy Pruritus Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 80 Italy Pruritus Therapeutics Market, 2023 - 2030, USD Million
  • TABLE 81 Italy Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
  • TABLE 82 Italy Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
  • TABLE 83 Italy Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
  • TABLE 84 Italy Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
  • TABLE 85 Italy Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 86 Italy Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 87 Rest of Europe Pruritus Therapeutics Market, 2019 - 2022, USD Million
  • TABLE 88 Rest of Europe Pruritus Therapeutics Market, 2023 - 2030, USD Million
  • TABLE 89 Rest of Europe Pruritus Therapeutics Market by Disease Type, 2019 - 2022, USD Million
  • TABLE 90 Rest of Europe Pruritus Therapeutics Market by Disease Type, 2023 - 2030, USD Million
  • TABLE 91 Rest of Europe Pruritus Therapeutics Market by Product, 2019 - 2022, USD Million
  • TABLE 92 Rest of Europe Pruritus Therapeutics Market by Product, 2023 - 2030, USD Million
  • TABLE 93 Rest of Europe Pruritus Therapeutics Market by Distribution Channel, 2019 - 2022, USD Million
  • TABLE 94 Rest of Europe Pruritus Therapeutics Market by Distribution Channel, 2023 - 2030, USD Million
  • TABLE 95 Key Information - Bristol Myers Squibb Company
  • TABLE 96 Key Information - Novartis AG
  • TABLE 97 Key Information - Pfizer, Inc.
  • TABLE 98 Key Information - Sanofi S.A.
  • TABLE 99 key information - Astellas Pharma, Inc.
  • TABLE 100 Key Information - Cara Therapeutics, Inc.
  • TABLE 101 Key Information - GlaxoSmithKline PLC
  • TABLE 102 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 103 Key Information - Amgen, Inc.
  • TABLE 104 Key information - AbbVie, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Europe Pruritus Therapeutics Market, 2019 - 2030, USD Million
  • FIG 3 Key Factors Impacting Pruritus Therapeutics Market
  • FIG 4 Porter's Five Force Analysis: Pruritus Therapeutics Market
  • FIG 5 Europe Pruritus Therapeutics Market share by Disease Type, 2022
  • FIG 6 Europe Pruritus Therapeutics Market share by Disease Type, 2030
  • FIG 7 Europe Pruritus Therapeutics Market by Disease Type, 2019 - 2030, USD Millio
  • FIG 8 Europe Pruritus Therapeutics Market share by Product, 2022
  • FIG 9 Europe Pruritus Therapeutics Market share by Product, 2030
  • FIG 10 Europe Pruritus Therapeutics Market by Product, 2019 - 2030, USD Million
  • FIG 11 Europe Pruritus Therapeutics Market share by Distribution Channel, 2022
  • FIG 12 Europe Pruritus Therapeutics Market share by Distribution Channel, 2030
  • FIG 13 Europe Pruritus Therapeutics Market by Distribution Channel, 2019 - 2030, USD Million
  • FIG 14 Europe Pruritus Therapeutics Market share by Country, 2022
  • FIG 15 Europe Pruritus Therapeutics Market share by Country, 2030
  • FIG 16 Europe Pruritus Therapeutics Market by Country, 2019 - 2030, USD Million
  • FIG 17 SWOT Analysis: Bristol Myers Squibb Company
  • FIG 18 SWOT Analysis: Novartis AG
  • FIG 19 SWOT Analysis: Pfizer, Inc.
  • FIG 20 Swot Analysis: Sanofi S.A.
  • FIG 21 SWOT Analysis: Astellas Pharma, Inc.
  • FIG 22 SWOT Analysis: CARA THERAPEUTICS, INC.
  • FIG 23 SWOT Analysis: GlaxoSmithKline PLC
  • FIG 24 Swot Analysis: Teva Pharmaceuticals Industries Ltd.
  • FIG 25 Swot Analysis: Amgen, Inc.
  • FIG 26 Swot Analysis: AbbVie, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!